Healthy volunteers test new drug combo in early safety trial
NCT ID NCT07128654
First seen Nov 17, 2025 · Last updated May 19, 2026 · Updated 20 times
Summary
This early-stage study tested the safety and how the body processes two experimental drugs (CTL0201 and CTL0202) given together or alone. Forty healthy adults aged 19 to 55 took a single dose and were monitored. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
H+ Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.